INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 180 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,165,183 | +476.8% | 62,847 | +522.2% | 0.08% | +1166.7% |
| Q2 2021 | $202,000 | -13.3% | 10,100 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $233,000 | -31.9% | 10,100 | -27.0% | 0.01% | -33.3% |
| Q4 2020 | $342,000 | +8450.0% | 13,830 | +13730.0% | 0.01% | – |
| Q3 2020 | $4,000 | -71.4% | 100 | -66.7% | 0.00% | -100.0% |
| Q2 2020 | $14,000 | +40.0% | 300 | +98.7% | 0.00% | – |
| Q3 2019 | $10,000 | -16.7% | 151 | -1.9% | 0.00% | -100.0% |
| Q2 2019 | $12,000 | -84.0% | 154 | -77.2% | 0.00% | -75.0% |
| Q1 2019 | $75,000 | +971.4% | 674 | +823.3% | 0.00% | – |
| Q4 2018 | $7,000 | -22.2% | 73 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $9,000 | -99.2% | 73 | -99.4% | 0.00% | -98.6% |
| Q2 2018 | $1,103,000 | +981.4% | 13,143 | +649.3% | 0.07% | +677.8% |
| Q3 2017 | $102,000 | -95.2% | 1,754 | -90.0% | 0.01% | -95.5% |
| Q2 2017 | $2,127,000 | +1189.1% | 17,567 | +1103.2% | 0.20% | +1156.2% |
| Q1 2017 | $165,000 | +111.5% | 1,460 | +192.0% | 0.02% | +45.5% |
| Q4 2014 | $78,000 | – | 500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |